CMS is shutting down the National Training Program, whose mission is "to communicate Medicare and other CMS-program information that...can be used to effectively train the public." The site will be discontinued Oct 15, the first day of Medicare 2026 open enrollment cmsnationaltrainingprogram.cms.gov

🚨CMS just announced that Medicare will NOT move forward with a proposal to require coverage of drugs used to treat obesity. This proposal was issued at the end of the Biden administration but it was up to the Trump administration to finalize, or not. www.cms.gov/newsroom/fac...

CMS makes it official: the Innovation Center will not move forward with the Medicare $2 drug list model, a Biden administration plan to test whether improved access to low-cost drugs would improve health outcomes, which Trump moved to cancel on day one of his second term. www.cms.gov/newsroom/fac...

With news that Social Security is implementing major workforce reductions, it's worth noting that the agency plays a big role in helping people enroll in Medicare by processing applications for Part A and B, as well as for the Part D drug benefit's extra help program. www.kff.org/faqs/medicar...

🚨 Round 2 of Medicare's drug price negotiation program just kicked off. The popular diabetes and obesity drugs Ozempic and Wegovy are at the top of the list. Medicare price negotiation could play a key role in increasing affordability and access to these drugs. www.kff.org/quick-take/w...

This proposal would also expand coverage under state Medicaid programs, which currently can but aren't *required* to cover drugs to treat obesity. Our new policy watch explains the implications of this proposed change for Medicare and Medicaid coverage and costs. www.kff.org/policy-watch...

The Biden administration has proposed to allow Medicare to cover anti-obesity drugs, which is currently prohibited by law. The proposals hinges on reinterpreting the statutory language to allow coverage when these drugs are used to treat obesity, which is now commonly regarded as a disease.

With 2 weeks left in #Medicare open enrollment, people in stand-alone #PartD drug plans are facing a lot of changes in the market, with fewer choices overall and higher premiums for some plans but lower premiums for others. More details in our analysis of the 2025 market: www.kff.org/medicare/iss...

For Medicare D, the law defines what drugs will and won't be covered >> drugs and vaccines that are approved by the Food & Drug Administration (with a few exceptions, like anti-obesity drugs). So Congress would need to change the law in order to change what drugs and vaccines Medicare covers.

NEW @kff.org calculator tool shows how much more ACA enrollees will pay if enhanced subsidies to expire www.kff.org/interactive/...

A key deadline for Medicare's drug price negotiation program will come soon after President-elect Trump is inaugurated: releasing the list of up to 15 drugs selected for round 2 of negotiation by Feb 1, 2025. Our updated FAQs has a timeline of key activities to watch. www.kff.org/medicare/iss...